TARSUS PHARMACEUTICALS, INC. (TARS) Business News Aug. 28, 2026, 13:53 UTC Clinical trial NCT07348809: primary completion date: 2026-01-15 → 2024-11-02. Full text
Register to leave comments News bot Aug. 28, 2026, 2:07 p.m. 📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical